# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: Clinical Criteria

Extent: E+W+S+N.I.

Any person with at least one of the following clinical forms:
Cutaneous anthrax
At least one the following two:
Papular or vesicular lesion;
Depressed black eschar with surrounding oedema.
Gastrointestinal anthrax
Fever or feverishness;
AND at least one of the following two:
Severe abdominal pain;
Diarrhoea.
Inhalational anthrax
Fever or feverishness;
AND at least one of the following two:
Acute respiratory distress;
Radiological evidence of mediastinal widening.
Meningeal/meningoencephalitic anthrax
Fever;
AND at least one of the following three:
Convulsions;
Loss of consciousness;
Meningeal signs.
Anthrax septicaemia

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/3/division/3.1/division/1 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-3/division-3.1/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.